SI-BONE, Inc. — Director's Dealing 2023

Nov 20, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SI-BONE, Inc. (SIBN)
CIK: 0001459839
Period of Report: 2023-11-16

Reporting Person: RECUPERO ANTHONY J (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-11-16	Common Stock	S	306.00	$17.3809	Disposed	208990.00	Direct
2023-11-16	Common Stock	S	1611.00	$17.7327	Disposed	207379.00	Direct
2023-11-16	Common Stock	S	1468.00	$17.6856	Disposed	205911.00	Direct
2023-11-16	Common Stock	S	2076.00	$17.6943	Disposed	203835.00	Direct
2023-11-17	Common Stock	S	2996.00	$17.7818	Disposed	200839.00	Direct

Footnotes

F1: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in
connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover"
transaction and does not represent a discretionary trade by the Reporting Person.

F2: This transaction was executed in multiple trades at prices ranging from $17.11 USD to $17.605 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the
Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the
range set forth in this footnote.

F3: This transaction was executed in multiple trades at prices ranging from $17.11 USD to $17.89 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the
Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the
range set forth in this footnote.

F4: This transaction was executed in multiple trades at prices ranging from $17.11 USD to $17.87 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the
Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the
range set forth in this footnote.

F5: This transaction was executed in multiple trades at prices ranging from $17.10 USD to $17.88 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the
Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the
range set forth in this footnote.

F6: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F7: The shares were sold in multiple transactions ranging from $17.56 to $17.99 USD; the price reported above reflects the weighted average sale price.The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F8: Includes 125,990 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit
represents a contingent right to receive one shares of the Issuer's common stock.